Spinal muscular atrophy is a debilitating neuromuscular disease that in its most severe form is the leading genetic cause of infant death. By experimenting with an ALS drug in two very different animal models, researchers have identified a new potential mechanism for developing an SMA treatment.

Source: A new approach for spinal muscular atrophy?


David Cottle

UBB Owner & Administrator